{"id":"https://openalex.org/W2159711942","doi":"https://doi.org/10.1200/jco.2009.22.0616","title":"Safety of Bevacizumab in Patients With Non\u2013Small-Cell Lung Cancer and Brain Metastases","display_name":"Safety of Bevacizumab in Patients With Non\u2013Small-Cell Lung Cancer and Brain Metastases","publication_year":2009,"publication_date":"2009-09-09","ids":{"openalex":"https://openalex.org/W2159711942","doi":"https://doi.org/10.1200/jco.2009.22.0616","mag":"2159711942","pmid":"https://pubmed.ncbi.nlm.nih.gov/19738122"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.22.0616","doi":"https://doi.org/10.1200/jco.2009.22.0616","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2009.22.0616","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.22.0616?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.22.0616?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090256464","display_name":"Corey Jay Langer","orcid":"https://orcid.org/0000-0002-8483-6811","observed_orcids":["https://orcid.org/0000-0002-8483-6811"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey J. Langer","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103464974","display_name":"Jane E. Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane E. Huang","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110018016","display_name":"Margaret M. Kolb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret M. Kolb","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108200513","display_name":"Peter G. Compton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Compton","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028677586","display_name":"Lisa E. Wang","orcid":"https://orcid.org/0000-0001-9726-0383","observed_orcids":["https://orcid.org/0000-0001-9726-0383"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Wang","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016686763","display_name":"Wallace Akerley","orcid":"https://orcid.org/0000-0002-3090-4778","observed_orcids":["https://orcid.org/0000-0002-3090-4778"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wallace Akerley","raw_affiliation_strings":["From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; University of Pennsylvania, Philadelphia, PA; Genentech, San Francisco, CA; and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I183934855","https://openalex.org/I2801159745","https://openalex.org/I4390039329","https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":26.646,"has_fulltext":true,"cited_by_count":240,"citation_normalized_percentile":{"value":0.99741519,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"27","issue":"31","first_page":"5255","last_page":"5261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5756999850273132,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5756999850273132,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.267300009727478,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0803999975323677,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9990000128746033},{"id":"https://openalex.org/keywords/central-nervous-system-hemorrhage","display_name":"central nervous system hemorrhage","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pulmonary-hemorrhage","display_name":"pulmonary hemorrhage","score":0.8100000023841858},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.968999981880188},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8510000109672546},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9929999709129333},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9314873218536377},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7936276197433472},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5648301839828491},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5431103706359863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4754478633403778},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4553968012332916},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.264146625995636}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2009.22.0616","doi":"https://doi.org/10.1200/jco.2009.22.0616","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2009.22.0616","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.22.0616?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:19738122","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19738122","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1200/jco.2009.22.0616","doi":"https://doi.org/10.1200/jco.2009.22.0616","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2009.22.0616","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.22.0616?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2159711942.pdf","grobid_xml":"https://content.openalex.org/works/W2159711942.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W97784689","https://openalex.org/W1785738486","https://openalex.org/W1973799874","https://openalex.org/W2055914441","https://openalex.org/W2056584585","https://openalex.org/W2057899218","https://openalex.org/W2078853297","https://openalex.org/W2094250419","https://openalex.org/W2100785570","https://openalex.org/W2106129813","https://openalex.org/W2109950864","https://openalex.org/W2138297714","https://openalex.org/W2145835533","https://openalex.org/W2153030337","https://openalex.org/W2158083369","https://openalex.org/W2158789700","https://openalex.org/W2162065895","https://openalex.org/W2168161641","https://openalex.org/W2170655985","https://openalex.org/W2240670822","https://openalex.org/W2336374857","https://openalex.org/W2417903924","https://openalex.org/W4237253263"],"related_works":["https://openalex.org/W2043714168","https://openalex.org/W2062347107","https://openalex.org/W2336374857","https://openalex.org/W2068863205","https://openalex.org/W2136371443","https://openalex.org/W2069510682","https://openalex.org/W3012539971","https://openalex.org/W1939215753","https://openalex.org/W2602204204","https://openalex.org/W2240670822"],"abstract_inverted_index":{"PURPOSE:":[0],"Patients":[1],"with":[2,46,70,83,97,157,254,267],"non-small-cell":[3],"lung":[4],"cancer":[5],"(NSCLC)":[6],"and":[7,48,62,92,128,168,203,234,256,264],"brain":[8,51,72,258],"metastases":[9,259],"have":[10],"previously":[11,49],"been":[12],"excluded":[13],"from":[14],"trials":[15],"of":[16,19,22,36,65,114,122,130,135,160,172,230,239,244,271],"bevacizumab":[17,33,77,96,162,245],"because":[18,238],"suspected":[20],"risk":[21],"CNS":[23,42,178,272],"hemorrhage.":[24,220,273],"This":[25,56],"phase":[26],"II":[27],"trial,":[28],"AVF3752g":[29],"(PASSPORT),":[30],"specifically":[31],"addressed":[32],"safety":[34],"(incidence":[35],"grade":[37,173,193,217],">":[38,174],"or":[39,87,100,105,175,250],"=":[40,176],"2":[41,177],"hemorrhage)":[43],"in":[44,252],"patients":[45,69,75,94,117,125,222,253],"NSCLC":[47,67,255],"treated":[50,71,257],"metastases.":[52,73],"PATIENTS":[53],"AND":[54],"METHODS:":[55],"open-label":[57],"multicenter":[58],"trial":[59],"for":[60],"first-":[61],"second-line":[63,93,124],"treatment":[64,202,226],"nonsquamous":[66],"enrolled":[68,111],"First-line":[74],"received":[76,95,118,126,132],"(15":[78],"mg/kg)":[79],"every":[80],"3":[81],"weeks":[82,208],"platinum-based":[84],"doublet":[85],"therapy":[86],"erlotinib":[88,251],"(at":[89],"physician's":[90],"decision),":[91],"single-agent":[98],"chemotherapy":[99,248],"erlotinib,":[101],"until":[102],"disease":[103,240],"progression":[104],"death.":[106],"RESULTS:":[107],"Of":[108,185],"the":[109,136,186,204,210],"115":[110],"patients,":[112,145],"66":[113],"76":[115],"first-line":[116],"carboplatin-based":[119],"chemotherapy;":[120],"22":[121,155],"39":[123,131],"pemetrexed,":[127],"nine":[129],"erlotinib.":[133],"As":[134],"June":[137],"23,":[138],"2008":[139],"data":[140,211],"cut,":[141],"among":[142],"106":[143],"safety-evaluable":[144],"median":[146,159],"on-study":[147],"duration":[148],"was":[149,214],"6.3":[150],"months":[151],"(range,":[152,164],"0":[153],"to":[154,166,183,246,261],"months),":[156],"a":[158,228,268],"five":[161],"cycles":[163],"one":[165,199,216],"17),":[167],"no":[169],"reported":[170],"episodes":[171],"hemorrhage":[179],"(95%":[180],"CI,":[181],"0.0%":[182],"3.3%).":[184],"bevacizumab-targeted":[187],"adverse":[188,232],"events":[189],"reported,":[190],"two":[191],"were":[192,196],"5.":[194],"Both":[195],"pulmonary":[197],"hemorrhages,":[198],"occurring":[200,206],"during":[201],"other":[205],"6":[207],"after":[209],"cut;":[212],"there":[213],"also":[215],"4,":[218],"nonpulmonary/non-CNS":[219],"Twenty-six":[221],"(24.5%)":[223],"discontinued":[224,237],"study":[225],"as":[227],"result":[229],"an":[231],"event,":[233],"37":[235],"(34.9%)":[236],"progression.":[241],"CONCLUSION:":[242],"Addition":[243],"various":[247],"agents":[249],"seems":[260],"be":[262],"safe":[263],"is":[265],"associated":[266],"low":[269],"incidence":[270]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":19},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":29},{"year":2013,"cited_by_count":25},{"year":2012,"cited_by_count":35}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}